Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
General skin proteins is a collective term for the various structural and functional proteins that constitute the skin's layers, primarily the epidermis and dermis. Key members include keratins, which form the intermediate filaments of the cytoskeleton in epithelial cells, and collagen and elastin, which provide the extracellular matrix with tensile strength and recoil properties (StatPearls, "Physiology, Skin"). Other significant proteins include filaggrin, which is vital for the assembly of the skin barrier and the production of natural moisturizing factors (NCBI, "The Skin Barrier"). In a clinical context, these proteins are often the indirect or non-specific targets of topical agents designed to enhance barrier function, promote wound healing, or mitigate the effects of aging. For example, keratolytics like salicylic acid work by breaking down keratin aggregates to treat hyperkeratotic conditions. Because this term refers to a broad class rather than a single molecular entity, it is generally considered a descriptive category in pharmacology rather than a specific drug target. Therapeutic strategies involving these proteins often focus on replacing lost components, such as collagen fillers, or protecting existing structures from environmental degradation. Monitoring the integrity of these proteins is essential in managing chronic skin diseases like atopic dermatitis and psoriasis.
Non-specific modulation of skin structural integrity and barrier function through physical protection, hydration, and keratolysis.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on General skin proteins.